{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:30:20Z","timestamp":1782109820185,"version":"3.54.5"},"reference-count":31,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec id=\"st1\">\n<jats:title>Background<\/jats:title>\n<jats:p>Meningioma is the most frequent primary benign intracranial tumor, with a higher incidence in women. Treatment with progesterone acetates, including cyproterone, nomegestrol, chlormadinone, promegestone, medrogestone, and medroxyprogesterone acetate, has been identified as a risk factor of meningioma, particularly in the anterior and middle cranial fossae. Discontinuation of these treatments often leads to volume stabilization or regression of the tumor.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st2\">\n<jats:title>Case Description<\/jats:title>\n<jats:p>A 42-year-old woman undergoing treatment with nomegestrol acetate (NA) presented with headaches and visual loss in her right eye. She was diagnosed with a large spheno-orbital meningioma invading the sphenoid and ethmoid sinuses, associated with hyperostosis of the sphenoid wing. An initial resection was performed using an extended endonasal approach. Immunohistochemistry confirmed a chondroid meningioma, Grade II, with progestin receptor in 100% of the tumor cell nuclei and a Ki-67 proliferation index of 3\u20135%. NA was immediately stopped on diagnosis. Despite the cessation of the NA, the intraosseous sphenoidal part of the tumor continued to grow, leading to optic nerve compression. A second surgery was performed using a right fronto-temporo-orbito-zygomatic approach. Examination of the dura of the middle fossa showed subtle tumoral infiltration, while the Ki-67% index was estimated at 1%. Examination of the sphenoid bone demonstrated reactive hyperostosis with minimal to no tumor infiltration.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st3\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This case illustrates that the proliferative activity of the progestin-associated meningioma does not account for intraosseous progression within the sphenoid bone following cessation of progestin therapy. Our observations suggest an upregulation of osteogenesis in infiltrated bone, even as the dural part of the meningioma regresses.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/sni_947_2024","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:13:15Z","timestamp":1745568795000},"page":"151","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Paradoxical evolution of spheno-orbital meningioma after cessation of progestin treatment"],"prefix":"10.25259","volume":"16","author":[{"given":"Maximilien","family":"Steinmetz","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, CHU Li\u00e8ge, Avenue de L\u2019h\u00f4pital, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lebeau","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, CHU Li\u00e8ge, Avenue de L\u2019h\u00f4pital, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bouchain","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, CHU Li\u00e8ge, Avenue de L\u2019h\u00f4pital, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mo\u00efse","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, CHU Li\u00e8ge, Avenue de L\u2019h\u00f4pital, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elettra","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Department of Anatomopathology, CHU Li\u00e8ge, Avenue de L\u2019h\u00f4pital, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Andris","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, CHU Li\u00e8ge, Avenue de L\u2019h\u00f4pital, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Catherine","family":"Chapelle","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, CHU Li\u00e8ge, Avenue de L\u2019h\u00f4pital, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axelle","family":"Pintiaux","sequence":"additional","affiliation":[{"name":"Department of Gynecology, CHU Li\u00e8ge, Avenue de L\u2019h\u00f4pital, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Reuter","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, CHU Li\u00e8ge, Avenue de L\u2019h\u00f4pital, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"10.25259\/SNI_947_2024\/ref-1","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00701-021-04781-8","article-title":"Sustained growth of intraosseous hormone-associated meningiomas after cessation of progestin therapy","volume":"163","author":"AbiJaoude","year":"2021","journal-title":"Acta Neurochir (Wien)"},{"key":"10.25259\/SNI_947_2024\/ref-2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11060-020-03576-8","article-title":"Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas","volume":"149","author":"Apra","year":"2020","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_947_2024\/ref-3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmg017","article-title":"Sex steroids and bone: Current perspectives","volume":"9","author":"Balasch","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.25259\/SNI_947_2024\/ref-4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1215\/15228517-2008-122","article-title":"Radiation-induced meningiomas: A shadow in the success story of childhood leukemia","volume":"11","author":"Banerjee","year":"2009","journal-title":"Neuro Oncol"},{"key":"10.25259\/SNI_947_2024\/ref-5","first-page":"438","article-title":"A prospective study of the natural history of incidental meningioma-hold your horses!","volume":"6","author":"Behbahani","year":"2019","journal-title":"Neurooncol Pract"},{"key":"10.25259\/SNI_947_2024\/ref-6","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00701-015-2532-3","article-title":"Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: A case series of 12 patients","volume":"157","author":"Bernat","year":"2015","journal-title":"Acta Neurochir (Wien)"},{"key":"10.25259\/SNI_947_2024\/ref-7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11060-020-03672-9","article-title":"Cyproterone acetate and meningioma: A nationwide-wide population based study","volume":"151","author":"Champeaux-Depond","year":"2021","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_947_2024\/ref-8","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3171\/2011.6.JNS11129","article-title":"Family and personal medical history and risk of meningioma","volume":"115","author":"Claus","year":"2011","journal-title":"J Neurosurg"},{"key":"10.25259\/SNI_947_2024\/ref-9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archopht.1929.00810010177003","article-title":"Meningiomas arising from the tuberculum sellae: With the syndrome of primary optic atrophy and bitemporal field defects combined with a normal sella turcica in a middle-aged person","volume":"1","author":"Cushing","year":"1929","journal-title":"Arch Ophthalmol"},{"key":"10.25259\/SNI_947_2024\/ref-10","doi-asserted-by":"crossref","first-page":"106959","DOI":"10.1016\/j.clineuro.2021.106959","article-title":"Preliminary report of patients with meningiomas exposed to cyproterone acetate, nomegestrol acetate and chlormadinone acetate-monocentric ongoing study on progestin related meningiomas","volume":"210","author":"Devalckeneer","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"10.25259\/SNI_947_2024\/ref-11","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s10143-021-01708-w","article-title":"Progestin-related WHO grade II meningiomas behavior-a single-institution comparative case series","volume":"45","author":"Devalckeneer","year":"2022","journal-title":"Neurosurg Rev"},{"key":"10.25259\/SNI_947_2024\/ref-12","doi-asserted-by":"crossref","first-page":"e774","DOI":"10.1016\/j.wneu.2018.04.176","article-title":"Meningioma and bone hyperostosis: Expression of bone stimulating factors and review of the literature","volume":"115","author":"Di Cristofori","year":"2018","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_947_2024\/ref-13","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3171\/2022.12.JNS222006","article-title":"Opposed evolution of the osseous and soft parts of progestin-associated osteomeningioma after progestin intake discontinuation","volume":"139","author":"Florea","year":"2023","journal-title":"J Neurosurg"},{"key":"10.25259\/SNI_947_2024\/ref-14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jmri.28067","article-title":"Magnetic resonance imaging versus computed tomography for three-dimensional bone imaging of musculoskeletal pathologies: A review","volume":"56","author":"Florkow","year":"2022","journal-title":"J Magn Reson Imaging"},{"key":"10.25259\/SNI_947_2024\/ref-15","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neuchi.2021.04.018","article-title":"Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome","volume":"67","author":"Graillon","year":"2021","journal-title":"Neurochirurgie"},{"key":"10.25259\/SNI_947_2024\/ref-16","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/ene.15423","article-title":"Risk of intracranial meningioma with three potent progestogens: A population-based case-control study","volume":"29","author":"Hoisnard","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.25259\/SNI_947_2024\/ref-17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11060-016-2121-1","article-title":"Parameters influencing local control of meningiomas treated with radiosurgery","volume":"128","author":"Kaprealian","year":"2016","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_947_2024\/ref-18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/neuros\/nyy121","article-title":"Familial syndromes involving meningiomas provide mechanistic insight into sporadic disease","volume":"83","author":"Kerr","year":"2018","journal-title":"Neurosurgery"},{"key":"10.25259\/SNI_947_2024\/ref-19","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3171\/2023.11.JNS23732","article-title":"Obesity and meningioma: A US population-based study paired with analysis of a multi-institutional cohort","volume":"140","author":"Khazanchi","year":"2024","journal-title":"J Neurosurg"},{"key":"10.25259\/SNI_947_2024\/ref-20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11060-021-03696-9","article-title":"Evolution of the neurosurgical management of progestin-associated meningiomas: A 23-year single-center experience","volume":"152","author":"Malaize","year":"2021","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_947_2024\/ref-21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/rp.57.1.385","article-title":"Sex steroids and bone","volume":"57","author":"Manolagas","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"10.25259\/SNI_947_2024\/ref-22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/neuonc\/noz005","article-title":"Body mass index, comorbidities, and hormonal factors in relation to meningioma in an ethnically diverse population: The multiethnic cohort","volume":"21","author":"Muskens","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.25259\/SNI_947_2024\/ref-23","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1212\/WNL.0000000000002020","article-title":"Body mass index, physical activity, and risk of adult meningioma and glioma: A meta-analysis","volume":"85","author":"Niedermaier","year":"2015","journal-title":"Neurology"},{"key":"10.25259\/SNI_947_2024\/ref-24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00701-019-03848-x","article-title":"Spontaneous regression of meningiomas after interruption of nomegestrol acetate: A series of three patients","volume":"161","author":"Passeri","year":"2019","journal-title":"Acta Neurochir (Wien)"},{"key":"10.25259\/SNI_947_2024\/ref-25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00701-012-1289-1","article-title":"Possible role of matrix metalloproteinases (MMPs) in hyperostosis of intracranial meningiomas","volume":"154","author":"Pei","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"10.25259\/SNI_947_2024\/ref-26","doi-asserted-by":"crossref","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","article-title":"CBTRUS Statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2017-2021","volume":"26","author":"Price","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.25259\/SNI_947_2024\/ref-27","doi-asserted-by":"crossref","first-page":"e078078","DOI":"10.1136\/bmj-2023-078078","article-title":"Use of progestogens and the risk of intracranial meningioma: National case-control study","volume":"384","author":"Roland","year":"2024","journal-title":"BMJ"},{"key":"10.25259\/SNI_947_2024\/ref-28","doi-asserted-by":"crossref","first-page":"e90167","DOI":"10.1371\/journal.pone.0090167","article-title":"Overweight, obesity and meningioma risk: A meta-analysis","volume":"9","author":"Shao","year":"2014","journal-title":"PLoS One"},{"key":"10.25259\/SNI_947_2024\/ref-29","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1056\/NEJMoa070972","article-title":"Incidental findings on brain MRI in the general population","volume":"357","author":"Vernooij","year":"2007","journal-title":"N Engl J Med"},{"key":"10.25259\/SNI_947_2024\/ref-30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/neuros\/nyab175","article-title":"Intracranial meningiomas decrease in volume on magnetic resonance imaging after discontinuing progestin","volume":"89","author":"Voormolen","year":"2021","journal-title":"Neurosurgery"},{"key":"10.25259\/SNI_947_2024\/ref-31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neurooncol"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/paradoxical-evolution-of-spheno-orbital-meningioma-after-cessation-of-progestin-treatment\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/paradoxical-evolution-of-spheno-orbital-meningioma-after-cessation-of-progestin-treatment\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:13:19Z","timestamp":1745568799000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/paradoxical-evolution-of-spheno-orbital-meningioma-after-cessation-of-progestin-treatment\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":31,"alternative-id":["10.25259\/SNI_947_2024"],"URL":"https:\/\/doi.org\/10.25259\/sni_947_2024","relation":{},"ISSN":["2152-7806","2229-5097"],"issn-type":[{"value":"2152-7806","type":"electronic"},{"value":"2229-5097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"article-number":"151"}}